36C24219Q0832-000.docx

DOCX document Posted

Attached to
Notice_of_Intent
Solicitation number
36C24219Q0832
Issued by

About this file

36C24219Q0832 36C24219Q0832.docx

View the file

Other files

File Type Posted
36C24219Q0832-000.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FedBizOpps Special Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field FedBizOpps Special Notice Rev. March 2010 Notice_of_Intent 10468-3904 36C24219Q0832 N 334516 Department of Veterans Affairs Network Contracting Office 2 James J. Peters VA Medical Center 130 West Kingsbridge Road Bronx NY 10468-3904 The Department of Veterans Affairs, James J. Peters Veterans Affairs Medical Center (VISN 2 South), intends to award a sole-source, firm fixed price FSS Delivery Order (FSS-DO) to Abbott Laboratories, Inc., FSS Contract #36F79719D0024, in accordance with FAR Subpart 8.405-6.

The acquisition sought is an FSS-DO that will cover consumables and supplies needed to produce a cost-per-reportable result (CPRR) and for the continued usage of contractor-owned equipment currently on-site at the James J. Peters Veterans Affairs Medical Center.

VA personnel utilize the equipment and consumables to perform in-house testing of immunosuppressants including, but not limited to, HIV Ag/Ab p-24, Tacrolimus, Sirolimus, Cyclosporine, Syphilis, Hemoglobin A1c, Estradiol, Anti-TG. The NAICS is 334516 with a small business size standard of 1,000 employees.

The current FSS-DO with Abbott Laboratories, Inc. will expire on September 30, 2019. The James J. Peters VA Medical Center is serving as a referral center for all kidney transplant Veteran patients for the East coast and throughout VISN2. This FSS-DO is required as part of the technical requirements to serve these transplant patients, 24/7 rapid assays for immunosuppressants including sirolimus, tacrolimus, and cyclosporine are required to be available.

This notice of intent is not a request for competitive proposals and no solicitation will be made available.

Any responses received no later than COB June 28, 2019 will be considered for the purposes of determining sources for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary.

This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.

File details come from the government source that posted it. Updated .